Trial Condition(s):

Dermatitis, Atopic

Efficacy and tolerance of once-daily methylprednisolone aceponate cream in comparison with twice-daily betamethasone valerate in patients with atopic dermatitis

Bayer Identifier:

Trial_89171

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

A multicenter, open, parallel group comparative study comparing the
therapeutic efficacy and tolerance of methylprednisolone aceponate
(MPA) 0.1% cream once-daily and twice-daily application of
betamethasone valerate (BMV) 0.1% cream in the treatment of
patients of both sexes suffering from atopic dermatitis.

Inclusion Criteria
:
 -  Atopic dermatitis, necessity of a therapy with a potent topical
corticosteroid on a cream base.
 -  Age ≥ 14 years
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
152
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Advantan (Methylprednisolone Aceponate, BAY86-4862)
Accepts Healthy Volunteers
No

Where to Participate

Locations
Status
LocationsStatus

Trial Design